Search results
Showing results for
Oxford University doctors and scientists are performing the second phase of clinical studies of an experimental Ebola vaccine regimen. The study is part of the EBOVAC2 project, a collaborative programme involving the University of Oxford, French Institute of Health and Medical Research (INSERM) as project coordinator, London School of Hygiene & Tropical Medicine, Le Centre Muraz, Inserm Transfert (IT) and the Janssen Pharmaceutical Companies of Johnson & Johnson.
Sir Andrew Pollard
BSc MBBS PhD (Lond), DIC, MRCP (UK), FHEA, FRCPCH, MA, FMedSci, FRS Sir Andrew Pollard - Ashall Professor of Infection & Immunity
Yama G.Farooq
BCA Computer Application , MSc in Information Technology and Software Engineering Yama G.Farooq - Programming and Data Management Director
Daniel O'Connor
BSc AFHEA MSc DPhil (OXON) Daniel O'Connor - Associate Professor | Head of Bioinformatics
Sarah Atkinson
MBBS, BSc, MRCPCH, DTM&H, PhD, PGDipPID Sarah Atkinson - Associate Professor and Honorary Consultant in Paediatrics and Paediatric Infectious Disease
Susanne Hodgson
BM BCh, MA, DTM&H, PGDipLATHE, MRCP, DPhil, FRCPath Susanne Hodgson - Associate Professor & Consultant Physician
